Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection

By LabMedica International staff writers
Posted on 31 Mar 2026

Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species. More...

Researchers now describe a prototype that parallelizes ion handling to improve sensitivity for low-abundance targets in challenging matrices. The findings show enhanced dynamic range and signal-to-noise, potentially enabling detection of molecules that were previously undetectable with standard ion traps.

Most current systems examine one or a few ion populations at a time, a limitation that can slow analyses, raise costs, and obscure scarce but informative molecules in single-cell proteomics and metabolomics. Because proteins and metabolites cannot be amplified like nucleic acids, faint signals are easily overwhelmed by background. Improving sensitivity and throughput is therefore a recurring bottleneck for comprehensive molecular readouts.

Investigators at Rockefeller University (New York, NY, USA) developed a prototype called MultiQ‑IT that cools, traps, filters, and redirects more than a billion ions simultaneously. Built to replace the core ion‑trapping stage, the cube‑shaped device is lined with hundreds of electrically controlled openings. Ions are slowed by collisions with residual gas, move stochastically within the chamber, and can be held or routed so that many ion populations are manipulated at once rather than one by one.

The team scaled the design from six openings to more than 1,000 and showed that a single incoming ion stream can be split into multiple parallel streams for simultaneous analysis. In a 486‑port configuration, MultiQ‑IT stored up to ten billion charges—about a thousand times the capacity of conventional ion traps. Applying a small voltage barrier across the exits allowed singly charged background ions to escape while retaining multiply charged, information‑rich ions, improving signal‑to‑noise by as much as 100‑fold and revealing previously undetectable proteins.

In a 1,134‑port design, just 39 open ports achieved half‑maximum depletion efficiency, echoing parallel transport seen in biological pores. The increased sensitivity could, for example, improve detection of low‑abundance crosslinked peptides used to map large protein complexes. The findings outline a physical blueprint for faster, more sensitive instruments and point toward routine, high‑throughput single‑cell proteomics. The work appears in Science Advances.

“It was the ability to run so many chemical reactions in parallel, which took genome sequencing from a billion-dollar effort to something that costs around $100. The same thing happened in computing with GPUs. And that’s what we’re trying to do with mass spectrometry,” said Brian T. Chait, the Camille and Henry Dreyfus Professor at The Rockefeller University.

Related Links
The Rockefeller University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
POC Immunoassay Analyzer
Procise DX
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers compared Huntington’s disease biomarkers in CSF and blood with clinical assessments and brain imaging to better understand changes before clinical onset (Image Credit: Adobe Stock)

Blood and Spinal Fluid Biomarker May Help Track Early Huntington’s Disease

Huntington’s disease is a genetic disorder caused by a mutation in the HTT gene that progressively affects movement, cognition, behavior, and independence. Although mutation carriers can be identified... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.